» Articles » PMID: 29236288

Disaster Preparedness: Biological Threats and Treatment Options

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2017 Dec 14
PMID 29236288
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Biological disasters can be natural, accidental, or intentional. Biological threats have made a lasting impact on civilization. This review focuses on agents of clinical significance, bioterrorism, and national security, specifically Category A agents (anthrax, botulism, plague, tularemia, and smallpox), as well as briefly discusses other naturally emerging infections of public health significance, Ebola virus (also a Category A agent) and Zika virus. The role of pharmacists in disaster preparedness and disaster response is multifaceted and important. Their expertise includes clinical knowledge, which can aid in drug information consultation, patient-specific treatment decision making, and development of local treatment plans. To fulfill this role, pharmacists must have a comprehensive understanding of medical countermeasures for these significant biological threats across all health care settings. New and reemerging infectious disease threats will continue to challenge the world. Pharmacists will be at the forefront of preparedness and response, sharing knowledge and clinical expertise with responders, official decision makers, and the general public.

Citing Articles

Patient flow management in biological events: a scoping review.

Hadinejad Z, Farrokhi M, Saatchi M, Ahmadi S, Khankeh H BMC Health Serv Res. 2024; 24(1):1177.

PMID: 39363291 PMC: 11451140. DOI: 10.1186/s12913-024-11502-1.


Knowledge, attitudes, and practices associated with bioterrorism preparedness in healthcare workers: a systematic review.

Li T, Zhang Y, Yao L, Bai S, Li N, Ren S Front Public Health. 2023; 11:1272738.

PMID: 37869204 PMC: 10587418. DOI: 10.3389/fpubh.2023.1272738.


Activity of Novel Topoisomerase Inhibitors against and .

Whelan A, Cooper I, Ooi N, Orr D, Blades K, Kirkham J Antibiotics (Basel). 2023; 12(6).

PMID: 37370302 PMC: 10326817. DOI: 10.3390/antibiotics12060983.


Antibiotic Stewardship in Disaster Situations: Lessons Learned in Lebanon.

Shallal A, Lahoud C, Zervos M, Matar M Antibiotics (Basel). 2022; 11(5).

PMID: 35625204 PMC: 9137475. DOI: 10.3390/antibiotics11050560.


Microbial ecology and evolution is key to pandemics: using the coronavirus model to mitigate future public health challenges.

Okeke E, Olovo C, Nkwoemeka N, Okoye C, Nwankwo C, Onu C Heliyon. 2022; 8(5):e09449.

PMID: 35601228 PMC: 9113781. DOI: 10.1016/j.heliyon.2022.e09449.